Head-to-head · WeighScore
JM Integrated Health vs Mevo Health
The verdict
Mevo Health takes it — 60.2/100 to 55.9/100.
Mevo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | JM Integrated Health | Mevo Health |
|---|---|---|
| WeighScore | 55.9/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #427 | #326 |
| Semaglutide | Not disclosed | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $259/mo (all doses, compounded) |
| Coverage | 6 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #427 · C
Strengths
- Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
- Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
- Six states clearly listed (TX, VT, NM, AZ, WA, NV)
- Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
- Publishes the FDA compounded-medication disclaimer
Where it loses points
- 503A pharmacy partner not named publicly
- Single-provider practice — enrollment is capacity-limited
- Only six states served, vs nationwide competitors
- Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
- No LegitScript certification displayed
Graded #326 · C
Strengths
- LegitScript verification badge on multiple pages
- Publishes the FDA compounded-medication disclaimer
- Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
- Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
- Public entry-level pricing surfaced
Where it loses points
- States served not listed on any public page
- Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
- No formal Medical Director role disclosed
- Only 'as low as' entry pricing shown — no per-dose itemization
- No SOC 2 certification claimed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.